Pathological Mechanisms and Novel Testing Methods in Thrombotic Thrombocytopenic Purpura
Thrombotic thrombocytopenic purpura (TTP) is an uncommon, but potentially disabling or even deadly, thrombotic microangiopathy with a well-studied mechanism of ADAMTS13 deficiency or dysfunction. While established treatments are largely effective, the standard ADAMTS13 testing required to definitive...
Main Authors: | Hallie H. Dolin, Robert W. Maitta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/3/621 |
Similar Items
-
Vaccination and Thrombotic Thrombocytopenic Purpura
by: İrfan Yavaşoğlu
Published: (2020-08-01) -
Hereditary Thrombotic Thrombocytopenic Purpura
by: Sanober Nusrat, et al.
Published: (2023-10-01) -
A Case of Acquired Thrombotic Thrombocytopenic Purpura: Three Recurrences in 25 Years
by: Şinasi Özsoylu
Published: (2015-07-01) -
Stress-induced hyperglycemia is associated with the mortality of thrombotic thrombocytopenic purpura patients
by: Lingling Hu, et al.
Published: (2024-02-01) -
COVID-19-associated thrombotic thrombocytopenic purpura (TTP); a case report
by: Ali Hajigholami, et al.
Published: (2023-01-01)